Diana Morgan | Nov 25, 1990 | 8 min read
NIDA offers financial and regulatory incentives, but reluctant pharmaceutical companies are worried about the legal risks WASHINGTON--The federal government wants to persuade the pharmaceutical industry to join its war on illegal drugs. At a two-day conference here this week the two sides will discuss financial and regulatory inducements to drug companies that create medications to fight mental illness to join the battle. Agencies within the Public Health Service are hoping that pharmaceutica